Document Detail


Long-Term Follow-Up of Intracranial Aneurysms Treated With Endovascular Coiling: Experience From One Institution.
MedLine Citation:
PMID:  22544871     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background: Our aim was to evaluate the long-term treatment results in patients with intracranial aneurysms treated with endovascular techniques. Methods: Forty-four patients treated due to intracranial aneurysms between 1996 and 2002 were investigated with a time-of-flight sequence magnetic resonance angiography (TOF MRA). Results: Depending on the assessment, 47% to 51% of the treated aneurysms had a residual neck at the last digital subtraction angiography follow-up. There was filling of the aneurysm base (2%) in only 1 patient, whereas the remaining aneurysms were totally occluded. A TOF MRA performed 6 to 14 (mean 9.68) years after the last procedure showed a stable result in 93.9% of the treated aneurysms. There were no de novo aneurysms and previously untreated aneurysms were unchanged in size. Conclusion: Our long-term follow-up showed a stable result in previously coiled intracranial aneurysms.
Authors:
Peter Lindvall; Ljubisa Borota; Richard Birgander; Per Jonasson; Per-Åke Ridderheim
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-27
Journal Detail:
Title:  Vascular and endovascular surgery     Volume:  -     ISSN:  1938-9116     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101136421     Medline TA:  Vasc Endovascular Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Technical Factors Affecting the Accuracy of Bedside IVC Filter Placement Using Intravascular Ultraso...
Next Document:  Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.